However, prior studies have reported elevations in blood‐derived GFAP levels across multiple dementia subtypes including vascular dementia, frontotemporal dementia, Parkinson's disease, and Creutzfeldt‐Jakob disease.17 This evidence concerns the gene GFAP and Parkinson disease.